NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/14/2026
Back to search
Official data from USPTO
TREXIOCEL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
TREXIOCEL
ST13
US500000079232497Class
5, 42, 44
Filing
79232497
Registration
5682721
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
05/15/2026
Trademark type
Word
Nice classes
5, 42, 44
Filing date
02/05/2018
Registration date
02/26/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/12/2025
Last transaction
05/15/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
28
Owner location
DE
Examiner
MIRANDA, JOHN
Law office
N20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
RHEACELL GmbH & Co. KG
Representatives
Claudia W. Stangle Leydig, Voit & Mayer, Ltd.
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical products in the nature of pharmaceutical preparations for the treatmentalleviation and healing of peripheral arterial diseases and wounds including peripheral arterial shutter-illness and diabetic foot ulcers; pharmaceutical products in the nature of pharmaceutical preparations for tissue repair and tissue regeneration
Class 42
Development of pharmaceutical preparations and substances in the nature of medicines; scientific and technological services in the nature of analysis and research in the field of pharmaceuticals; industrial analysis and research servicesindustrial research in the field of pharmaceuticals and scientific and technological analysis in the field of pharmaceuticals
Class 44
Medical services
Publications
History of USPTO decisions and trademark events.
36 publications found
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
05/12/2026
C71T
CANCELLED SECTION 71
09/12/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
02/26/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/05/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/15/2019
FIMP
FINAL DISPOSITION PROCESSED
06/15/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/26/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
02/26/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/11/2018
PUBO
PUBLISHED FOR OPPOSITION
12/11/2018
GPNX
NOTIFICATION PROCESSED BY IB
12/08/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/21/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/21/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/21/2018
ALIE
ASSIGNED TO LIE
11/01/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/18/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/17/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/17/2018
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
10/17/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/01/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/01/2018
CNFR
FINAL REFUSAL MAILED
09/11/2018
CNFR
FINAL REFUSAL WRITTEN
09/10/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/23/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/22/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/22/2018
RFNP
REFUSAL PROCESSED BY IB
06/30/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/11/2018
RFRR
REFUSAL PROCESSED BY MPU
06/11/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/02/2018
CNRT
NON-FINAL ACTION WRITTEN
06/01/2018
MAFR
APPLICATION FILING RECEIPT MAILED
05/29/2018
DOCK
ASSIGNED TO EXAMINER
05/25/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/25/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/24/2018
Continuous trademark protection
Get notified about every new filing that threatens TREXIOCEL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.